SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-20-018666
Filing Date
2020-08-25
Accepted
2020-08-25 16:03:50
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 navb20200824_s3.htm S-3 261452
2 EXHIBIT 4.5 ex_201354.htm EX-4.5 96312
3 EXHIBIT 5.1 ex_201355.htm EX-5.1 7625
4 EXHIBIT 23.2 ex_201356.htm EX-23.2 3045
5 navb20200824_s3img001.jpg GRAPHIC 5597
6 thlogo01.jpg GRAPHIC 12139
7 thlogo02.jpg GRAPHIC 14244
  Complete submission text file 0001437749-20-018666.txt   413949
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248404 | Film No.: 201132296
SIC: 2835 In Vitro & In Vivo Diagnostic Substances